Stifel Financial
AGIO icon

Stifel Financial’s Agios Pharmaceuticals AGIO Stock Holding History

Stifel Financial’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-16,738
Closed -$799K – 2810
2019
Q4 		$799K Buy
+16,738
New +$633K ﹤0.01% 1980
2015
Q4 		– Sell
-3,292
Closed -$232K – 2330
2015
Q3 		$232K Buy
3,292
+253
+8% +$24.7K ﹤0.01% 1947
2015
Q2 		$339K Buy
3,039
+335
+12% +$36.1K ﹤0.01% 1892
2015
Q1 		$255K Buy
+2,704
New +$303K ﹤0.01% 1987

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Stifel Financial's AGIO Position: Q1 2020 in Review

Stifel Financial sold out of Agios Pharmaceuticals (AGIO) in Q1 2020, closing a stake of 16,738 shares — an estimated $799K sold.

Stifel Financial first reported a position in AGIO in Q1 2015 and held it in 4 quarters. The position peaked at $799K in Q4 2019. 197 funds tracked by Wall St. Rank hold AGIO as of Q1 2020.

  • Stifel Financial reported no remaining Agios Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Stifel Financial sold 16,738 Agios Pharmaceuticals shares in Q1 2020, an estimated $799K.
  • Stifel Financial first reported a position in Agios Pharmaceuticals in Q1 2015 and held it in 4 quarters.
  • Stifel Financial's Agios Pharmaceuticals position peaked at $799K in Q4 2019.
  • 197 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2020.

Based on Stifel Financial's 13F filing for Q1 2020, filed 14 May 2020.